European Business Award 2015/16: Abiogen Pharma Named Italian National Champion

USA - English

• USA - Français
• USA - español
• USA - Deutsch
• India - English

PISA, Italy, December 3, 2015 /PRNewswire/ --

Abiogen Pharma has been named as a National Champion for Italy in The European Business Awards, a prestigious competition supported by businesses leaders, academics, media and political representatives from across Europe.  

     (Photo: http://photos.prnewswire.com/prnh/20151130/291864 )

The European Business Awards now in its 9^th year engaged with over 32,000 businesses from 33 European countries this year and 678 companies from across Europe have been named as National Champions; going through to the second phase of the competition. Abiogen Pharma, founded in 1997 and based in Pisa is a pharmaceutical company with a strong focus on internationalization. Its success is based on R&D and the distribution of primary pharmaceutical products, in areas such as bone metabolism, pain relief and respiratory, metabolic and dermatologic diseases.

Massimo di Martino, President & CEO of Abiogen Pharma, declares: "We've been able to create an outstanding team that allows us to achieve exceptional results. The foundation of our way of doing business is the introduction of innovative therapies that contribute to fight several diseases and, thus, improve the health of patients. We're very proud to be selected to represent Italy as a National Champion. The European Business Awards is widely recognised as the showcase for Europe's most dynamic companies and we are now looking forward to the next round of the judging process."

Adrian Tripp, CEO of the European Business Awards said: "Congratulations to Abiogen Pharma and all the companies that have been selected to represent their country as National Champions, they play an important part in creating a stronger business community."

The next round requires the National Champions to make a presentation video, telling their unique story and explaining their business success. The judges will view all of the National Champions' videos, and award the best of this group the coveted 'Ruban d'Honneur' status. Ruban d'Honneur recipients will then go on to be part of the grand final in 2016.

Separately, the National Champion videos will be made public on the European Business Awards website http://www.businessawardseurope.com as part of a two stage public vote, which will decide the 'National Public Champions' for each country.

In the 2014/15 competition, all EU member markets were represented, their combined revenue exceeded €1.5 trillion, and together they generated profits of over 60 billion Euros and employ over 2.5 million people.

SOURCE Abiogen Pharma